advagraf prolonged release hard capsules 1 mg
astellas pharma singapore pte. ltd. - tacrolimus monohydrate 1.02 mg eqv anhydrous tacrolimus 1.0 mg - capsule, extended release - 1.0 mg - tacrolimus monohydrate 1.02 mg eqv anhydrous tacrolimus 1.0 mg 1.0 mg
advagraf prolonged release hard capsules 5 mg
astellas pharma singapore pte. ltd. - tacrolimus monohydrate 5.1 mg eqv anhydrous tacrolimus 5.0 mg - capsule, extended release - 5.0 mg - tacrolimus monohydrate 5.1 mg eqv anhydrous tacrolimus 5.0 mg 5.0 mg
vesitirim 1 mg/ml oral suspension
astellas pharma co. limited - solifenacin succinate - oral suspension - 1 milligram(s)/millilitre - drugs for urinary frequency and incontinence; solifenacin - urologicals, drugs for urinary frequency and incontinence - symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.
advagraf 0.5 mg
astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 0.5 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.
advagraf 1 mg
astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 1 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.
advagraf 3 mg
astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 3 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.
advagraf 5 mg
astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 5 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.
xospata 40 mg
astellas pharma international b.v., israel - gilteritinib as fumarate - film coated tablets - gilteritinib as fumarate 40 mg - gilteritinib - xospata is indicated as monotherapy for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (aml) with a flt3 mutation
betmiga ® prolonged-release tablets 25mg
astellas pharma singapore pte. ltd. - mirabegron - tablet, film coated, extended release - 25 mg - mirabegron 25 mg
betmiga ® prolonged-release tablets 50mg
astellas pharma singapore pte. ltd. - mirabegron - tablet, film coated, extended release - 50 mg - mirabegron 50 mg